FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) submitted by Novartis, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Ritalin (methylphenidate)

Snippet

SUPPL AP for RITALIN (METHYLPHENIDATE HYDROCHLORIDE)